2019
DOI: 10.15585/mmwr.mm6839e2
|View full text |Cite
|
Sign up to set email alerts
|

E-cigarette Product Use, or Vaping, Among Persons with Associated Lung Injury — Illinois and Wisconsin, April–September 2019

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
54
0
6

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 84 publications
(67 citation statements)
references
References 7 publications
7
54
0
6
Order By: Relevance
“…Nationwide, 80% of hospitalized EVALI patients reported use of THC-containing e-cigarette, or vaping, products, and 56% of EVALI patients with data on product use specifically reported using Dank Vapes in the 3 months preceding symptom onset (4). Similar results have been reported in Illinois, Wisconsin (5), and Utah (6), which, together, suggest that Dank Vapes and other illicit THC-containing products obtained from informal sources played a major role in the nationwide EVALI outbreak. The current findings reinforce this relationship by linking multiple EVALI patients to the same illicit THC cartridges.…”
Section: Discussionsupporting
confidence: 84%
“…Nationwide, 80% of hospitalized EVALI patients reported use of THC-containing e-cigarette, or vaping, products, and 56% of EVALI patients with data on product use specifically reported using Dank Vapes in the 3 months preceding symptom onset (4). Similar results have been reported in Illinois, Wisconsin (5), and Utah (6), which, together, suggest that Dank Vapes and other illicit THC-containing products obtained from informal sources played a major role in the nationwide EVALI outbreak. The current findings reinforce this relationship by linking multiple EVALI patients to the same illicit THC cartridges.…”
Section: Discussionsupporting
confidence: 84%
“…Among EVALI patients, careful and comprehensive discharge planning ensuring clinical stability before discharge, follow-up optimally within 48 hours after hospital discharge, and enhanced efforts to coordinate care and address comorbidities might minimize risk for rehospitalizations or death after discharge (5). The latest national and state data from patient reports and product sample testing suggest tetrahydrocannabinol-containing e-cigarette, or vaping, products, particularly from informal sources such as friends, family members, or in-person or online dealers, are linked to most of the cases and play a major role in the outbreak (1,7,8). Thus, CDC and FDA recommend that persons not use tetrahydrocannabinol -containing e-cigarette, or vaping, products, particularly from informal sources.…”
Section: Discussionmentioning
confidence: 99%
“…This outbreak might have more than one cause, and many different substances and product sources are still under investigation. To date, national and state data suggest that products containing THC, particularly those obtained off the street or from other informal sources (eg, friends, family members, or illicit dealers), are linked to most of the cases and play a major role in the outbreak . Therefore, CDC recommends that persons should not use e‐cigarette, or vaping, products that contain THC.…”
Section: Clinical Care and Public Health Recommendationsmentioning
confidence: 99%